|
| 36075495 | Viral clade is associated with severity of symptomatic genotype 3 hepatitis E virus infections in Belgium, 2010-2018. | J Hepatol | 2023 |
| 37800269 | Denial and Delusions of an Aircraft Pilot with Alcohol Dependence: a Case Report. | Psychiatr Danub | 2023 |
| 37662449 | Alcohol-associated bowel disease: new insights into pathogenesis. | eGastroenterology | 2023 |
| 37060262 | Serum keratin 18-M65 levels detect progressive forms of alcohol-associated liver disease in early noncirrhotic stages. | Alcohol Clin Exp Res (Hoboken) | 2023 |
| 37058088 | Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans. | Hepatol Commun | 2023 |
| 37013368 | Links between psychopathological symptoms and cortical thickness in men with severe alcohol use disorder: A Magnetic Resonance Imaging study. | Neuropsychopharmacol Rep | 2023 |
| 36765087 | Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. | Nat Commun | 2023 |
| 36706195 | Malassezia restricta promotes alcohol-induced liver injury. | Hepatol Commun | 2023 |
| 36893735 | Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease. | Cell Host Microbe | 2023 |
| 36631002 | Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome. | Hepatology | 2023 |
| 34923905 | Restoring an adequate dietary fiber intake by inulin supplementation: a pilot study showing an impact on gut microbiota and sociability in alcohol use disorder patients. | Gut Microbes | 2022 |
| 35368152 | Intestinal virome in patients with alcohol use disorder and after abstinence. | Hepatol Commun | 2022 |
| 35490461 | Liver alterations are not improved by inulin supplementation in alcohol use disorder patients during alcohol withdrawal: A pilot randomized, double-blind, placebo-controlled study. | EBioMedicine | 2022 |
| 35629937 | Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder. | Metabolites | 2022 |
| 36422247 | Correlation between Serum Steroid Hormones and Gut Microbiota in Patients with Alcohol-Associated Liver Disease. | Metabolites | 2022 |
| 35919965 | Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans. | Aliment Pharmacol Ther | 2022 |
| 34992134 | Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. | Gut | 2022 |
| 35138516 | Liver Decompensation after Bariatric Surgery in the Absence of Cirrhosis. | Obes Surg | 2022 |
| 34896404 | The fecal mycobiome in non-alcoholic fatty liver disease. | J Hepatol | 2022 |
| 33151407 | The gut mycobiome: a novel player in chronic liver diseases. | J Gastroenterol | 2021 |
| 33667732 | Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible? | Clin Res Hepatol Gastroenterol | 2021 |
| 33639706 | Gastro-intestinal symptoms are associated with a lower in-hospital mortality rate in frail older patients hospitalized for COVID-19. | Acta Gastroenterol Belg | 2021 |
| 33639690 | Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents. | Acta Gastroenterol Belg | 2021 |
| 34884492 | Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease. | Int J Mol Sci | 2021 |
| 34822424 | Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease. | Metabolites | 2021 |
| 34599147 | Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms. | Transl Psychiatry | 2021 |
| 34349667 | Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder. | Front Physiol | 2021 |
| 34217187 | Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC). | Acta Gastroenterol Belg | 2021 |
| 33933733 | Dietary fiber deficiency as a component of malnutrition associated with psychological alterations in alcohol use disorder. | Clin Nutr | 2021 |
| 34360818 | Critical Role of LSEC in Post-Hepatectomy Liver Regeneration and Failure. | Int J Mol Sci | 2021 |
| 34087426 | Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity? | Clin Res Hepatol Gastroenterol | 2021 |
| 31228214 | Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis. | Hepatology | 2020 |
| 31926243 | 1,8-Cineole promotes G0/G1 cell cycle arrest and oxidative stress-induced senescence in HepG2 cells and sensitizes cells to anti-senescence drugs. | Life Sci | 2020 |
| 33053357 | Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use Disorder. | Cell Rep | 2020 |
| 33321019 | Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises. | Acta Gastroenterol Belg | 2020 |
| 32628772 | Deficiency of Intestinal α1-2-Fucosylation Exacerbates Ethanol-Induced Liver Disease in Mice. | Alcohol Clin Exp Res | 2020 |
| 32654263 | Intestinal Virome in Patients With Alcoholic Hepatitis. | Hepatology | 2020 |
| 32766476 | Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co-Metabolism in Patients With Alcoholic Hepatitis. | Hepatol Commun | 2020 |
| 32652145 | Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease. | Gastroenterology | 2020 |
| 32588725 | Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. | Gut Microbes | 2020 |
| 32390870 | Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder. | Front Physiol | 2020 |
| 31606552 | The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. | J Hepatol | 2020 |
| 30448775 | Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. | Gut | 2019 |
| 31723265 | Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. | Nature | 2019 |
| 30106835 | Fibroscan Reliably Rules Out Advanced Liver Fibrosis and Significant Portal Hypertension in Alcoholic Patients. | J Clin Gastroenterol | 2019 |
| 30031625 | The gut microbiota: A new target in the management of alcohol dependence? | Alcohol | 2019 |
| 31438880 | Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital. | BMC Infect Dis | 2019 |
| 31206267 | [What is the role of the gut microbiota in the development of alcohol use disorders?] | Rev Med Liege | 2019 |
| 31314202 | Results of a screening campaign for hepatitis C viral infection in a Brussels hospital : do we need to go further? | Acta Gastroenterol Belg | 2019 |
| 31311938 | Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. | Nat Commun | 2019 |